Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P) is a processed pseudogene related to the 7SL RNA, a non-coding RNA that is the RNA component of the signal recognition particle (SRP)[1][3][6]. Functional 7SL RNA is essential for targeting secretory proteins to the endoplasmic reticulum by pausing their translation and facilitating membrane translocation[4][5]. However, pseudogenes such as RN7SL789P are nonfunctional sequences derived from 7SL that do not encode a functional RNA product, do not participate in protein targeting, and are not known to have a regulatory or enzymatic role[2][3][6].\nMost human 7SL-related genomic sequences are pseudogenes, resulting from retrotranspositional events and gene duplication, and typically display truncated or mutated sequences preventing their function[3][6]. There is no evidence that RN7SL789P is a therapeutic target, nor is it implicated in any known disease processes, drug interactions, or safety concerns.\nThis is not a canonical molecular target but merely a relic of genomic evolution and is generally annotated for completeness in genomic analyses[2][3][6].\n\nKey points:\n- RN7SL789P is a pseudogene: it does not code for a functional RNA or protein and has no known physiological or pathological function[1][2][3][6].\n- Not a drug target: It is not considered a therapeutic target, receptor, enzyme, transporter, or regulatory RNA in any context[1].\n- No biomarker or disease association: There are no clinical, diagnostic, or therapeutic roles described[1][3][6].\n- Is_incorrect = true: Listing this as a drug/therapeutic target is incorrect; it is a non-functional genomic sequence (pseudogene)[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P).